🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Carriers of certain #Alzheimer’s mutations are eligible for DIAN-TU clinical trials. Variant eligibility is now noted in the Alzforum Mutations database. ow.ly/M6CP50VE9Ra

Great article by Dr. Roberta Diaz Brinton, featured in the New York Times this week discussing her promising work using allopregnanolone, a neurosteroid derived from progesterone, as a potential regenerative therapy for Alzheimer’s disease. nytimes.com/2025/04/22/hea…

🧠 #CTAD25 announces its keynote speakers: 🔹 Ronald DeMattos (Eli Lilly) 🔹 Peter Johannsen (Novo Nordisk) 🔹 Sid O’Bryant (UNT Health) 📅 Dec 1–4, 2025, San Diego 👉 ctad-alzheimer.com/call-abstracts… #AlzheimersResearch #Neuroscience #CTAD25 #ClinicalTrials

🧠 Discover the latest on #CTAD25! GeriatricArea just published a great article on the key themes of this year’s conference. 📅Dec 1–4 / San diego 📢Abstract submissions open until June 2! 📰Read it here: bit.ly/CTAD25Geriatri… #AlzheimersResearch #ClinicalTrials #Geriatrics

Join us for the 18th Clinical Trials on Alzheimer’s Disease Conference — the global hub for innovation in Alzheimer’s clinical research. Register now to secure your spot lnkd.in/d8S7mmwv Your ideas can make a difference !! #Alzheimers #ClinicalTrials #CTAD25

Join the 18th #CTAD25 — the global hub for #Alzheimers clinical research! 📍San Diego or online 🧠Discover the latest advances in Alzheimer’s drug development 📝Submit your abstract by June 2: lnkd.in/efnGAnU 🔗Register: lnkd.in/d8S7mmwv #ClinicalTrials #CTAD25

Invading CD8 killer T cells spotted in the midbrains of people with progressive supranuclear palsy add another neurodegenerative disease to the cells’ rap sheet. University of Toronto ow.ly/6YUM50VQrSo

Bravo to A. Turesson, former visiting researcher at the Institute on Aging in Toulouse, for "The associations between biological markers of aging and appetite loss across adulthood: retrospective case-control data from the INSPIRE-T study." pubmed.ncbi.nlm.nih.gov/40347354/ Bruno Vellas

This is the perfect opportunity to elevate your company's visibility 🧠 The #CTAD25 BIOTECH SESSIONS will be held during coffee breaks, and are designed to highlight emerging biotech innovations. Apply now, or express your interest when submitting your abstract or registering.

The 18th annual Clinical Trials on Alzheimer’s Disease Conference A must-attend event for clinicians, researchers, and innovators committed to improving patient outcomes. Watch the video to learn more about #CTAD25

ADI is delighted to announce that the 78th World Health Assembly has agreed to extend the Global Action Plan on the Public Health Response to Dementia by 6-years, marking a momentous decision, that will have an impact for the decades to come, for the more than 55 million people

Karen Harris, CFO & Head of Mission-Related Investments, highlights the critical role of philanthropy, public and private funding in driving scientific innovation. Protecting the biotech ecosystem is key to sustaining breakthroughs and the pipeline. The Wall Street Journal on.wsj.com/44S6ucu

Protective genetic variants against Alzheimer's disease - The Lancet Neurology thelancet.com/journals/laneu…

🚨 Final call! Submit your abstract for #CTAD25 by TONIGHT, June 2 at 11:59 PM PT 🕛 Showcase your Alzheimer’s clinical research at the global hub for innovation. 🔗 Submit now: secure.key4events.com/key4register/a… 📅 Dec 1–4, 2025 | San Diego, USA #Alzheimers #ClinicalTrials #CTADSanDiego

🚨 Abstract submissions close TONIGHT! 📅 Deadline: June 2 at 11:59 PM (PT) 📍CTAD 2025 brings together global leaders in Alzheimer’s research. Don’t miss your chance to present! 📝 Submit now: secure.key4events.com/key4register/a… #CTAD2025 #AlzheimersResearch

🚨 Just a few hours left! Abstract submissions for CTAD 2025 close tonight at 11:59 PM (PT). Be part of the global effort to advance Alzheimer’s research. Present your work alongside leading teams in clinical R&D. 📝 Submit now: secure.key4events.com/key4register/a… #Alzheimers #CTAD25

On behalf of the #CTAD2025 Scientific Committee, thank you for your abstract submissions! Missed the 1st call? 📢 Late-breaking call opens Aug 1–Sept 30. 🧠 Share your latest findings in San Diego, Dec 1–4. 🔗 lnkd.in/efnGAnU #AlzheimersResearch #ClinicalTrials